Related by context. All words. (Click for frequent words.) 70 neurocognitive deficits 70 extrapyramidal symptoms 70 dopaminergic therapy 70 mania hypomania 70 TEAEs 69 venlafaxine Effexor 69 parkinsonian symptoms 68 neurologic symptoms 68 Hepatotoxicity 68 autonomic dysfunction 68 efalizumab 68 hepatotoxicity 68 idiopathic Parkinson disease 68 myopathy rhabdomyolysis 68 neuropsychological impairments 68 haloperidol Haldol 67 hypoglycemic episodes 67 riociguat 67 hyperprolactinemia 67 atypical antipsychotic medications 67 comorbid disorders 67 neurocognitive functioning 67 QT prolongation 67 neurocognitive impairment 67 neuroleptics 67 tegaserod 67 risperidone Risperdal 67 quetiapine Seroquel 67 depressive symptomatology 67 macrovascular disease 67 overactive bladder symptoms 67 oxcarbazepine 66 RoACTEMRA 66 neuroleptic 66 Torsades de Pointes 66 QT interval prolongation 66 SRBD 66 clomipramine 66 somatic symptoms 66 Major Depressive Disorder 66 comorbid depression 66 Hypotension 66 VaD 66 fluoxetine Prozac 66 Tardive dyskinesia 66 Exacerbations 66 unmeasured confounders 66 Mood disorders 66 prolonged QT interval 66 zafirlukast 66 tiagabine 66 behavioral disturbances 66 akathisia 66 INVEGA R 66 paroxetine Paxil 66 Peripheral edema 66 generalized anxiety disorder GAD 66 Generalized Anxiety Disorder 66 Excessive daytime sleepiness 66 QTc prolongation 66 KETEK 65 impaired cognition 65 psychiatric comorbidities 65 thyrotoxicosis 65 dyslipidaemia 65 CTEPH 65 intravenous bisphosphonates 65 torsades de pointes 65 Topiramate 65 proliferative diabetic retinopathy 65 newer atypical antipsychotics 65 alexithymia 65 Primary IGFD 65 OSAHS 65 induce orthostatic hypotension 65 HeFH 65 chromium picolinate supplementation 65 antiplatelet medications 65 hypoglycaemic episodes 65 Cognitive impairment 65 Restless Legs Syndrome RLS 65 amisulpride 65 AGILECT R 65 hyperammonemia 65 Atypical antipsychotics 65 reflux symptoms 65 Comorbid 65 polyarticular 65 unprovoked seizures 65 Subgroup analyzes 65 hematological toxicity 65 tricyclic antidepressant 65 hypocalcemia 65 lipid abnormalities 65 mitochondrial toxicity 65 HIV HCV coinfected 65 cardiac valvulopathy 65 INVEGA ® 65 dermatologic reactions 65 neuropsychiatric events 65 RISPERDAL ® 65 Lamotrigine 65 juvenile idiopathic arthritis 65 torsade de pointes 65 EXJADE 65 anticholinergic drugs 65 T2DM 65 pediatric bipolar disorder 65 atypical neuroleptics 65 β blockers 65 hypochondriasis 65 NMDA receptor antagonists 65 hematologic toxicity 65 AGILECT ® 65 RLAI 65 multi infarct dementia 65 EFFEXOR XR 65 comorbid psychiatric 65 parkinsonism 65 desmopressin 65 ALT flares 65 diabetic polyneuropathy 65 GH deficiency 65 stimulant medications 64 flecainide 64 agomelatine 64 Suicidal ideation 64 akinetic mutism 64 poststroke depression 64 hematologic parameters 64 T1DM 64 hypersomnia 64 hereditary predisposition 64 lipid lowering agents 64 serotonin reuptake inhibitors 64 vasomotor symptoms 64 STEP BD 64 hypercalcemia 64 Hypocalcemia 64 clobazam 64 subclinical hypothyroidism 64 anticholinergic effects 64 neuropsychiatric adverse 64 psychiatric comorbidity 64 intensive statin therapy 64 syncopal 64 aldosterone antagonists 64 bezafibrate 64 glitazones 64 pancytopenia 64 hyperglycaemia 64 juvenile idiopathic arthritis JIA 64 parkinsonian 64 frequent awakenings 64 cytopenias 64 vertigo dizziness 64 HMG CoA reductase inhibitors 64 diabetic kidney 64 CONCERTA ® 64 transaminase elevations 64 androgen deficiency 64 coinfected patients 64 euthymic patients 64 cognitive deficits 64 renal toxicity 64 solifenacin 64 neuropsychological deficits 64 migraine prophylaxis 64 myoclonus 64 VIIBRYD 64 MGUS 64 pulmonary hypertension PH 64 cholinesterase inhibitors 64 monoamine oxidase inhibitors 64 sertraline Zoloft 64 Erythropoietic therapies may 64 psoriatic arthritis PsA 64 premenstrual syndrome PMS 64 ziprasidone Geodon 64 HRQL 64 placebo controlled clinical trials 63 oral antidiabetes drugs 63 memantine Namenda 63 donepezil 63 methodological limitations 63 headache abdominal pain 63 status epilepticus 63 anticonvulsants 63 tardive dyskinesia TD 63 neurological manifestations 63 pyridostigmine 63 conventional antipsychotics 63 fluoxetine paroxetine 63 abrupt discontinuation 63 Fanconi syndrome 63 affective disorders 63 myeloproliferative diseases 63 venlafaxine XR 63 aldosterone antagonist 63 apneic episodes 63 sulphonylureas 63 cerebrovascular events 63 airway hyperresponsiveness 63 placebo controlled studies 63 cytopenia 63 pentoxifylline 63 placebo controlled trials 63 levodopa therapy 63 hypercholesterolaemia 63 hyperphenylalaninemia HPA due 63 antimuscarinic 63 Sleep disturbances 63 NOMID 63 narcolepsy cataplexy 63 atherothrombotic 63 colorectal adenoma 63 anticonvulsant medications 63 antiepileptic drugs 63 attention-deficit/hyperactivity disorder ADHD 63 citalopram Celexa 63 cerivastatin 63 neurological abnormalities 63 severe hypersensitivity reactions 63 APTIVUS r 63 hippocampal atrophy 63 adrenal insufficiency 63 chronic urticaria 63 Paxil paroxetine 63 clozapine Clozaril 63 hypomagnesemia 63 primary aldosteronism 63 daytime drowsiness 63 STRIDE PD 63 anticholinergic agents 63 thrombotic events 63 postmarketing surveillance 63 vitamin D inadequacy 63 Severe Primary IGFD 63 carotid atherosclerosis 63 IBS C 63 haematologic 63 anticholinergic medications 63 cerebral microbleeds 63 Selective Serotonin Reuptake Inhibitor 63 antiepileptic medications 63 NAbs 63 Cariprazine 63 Chronic insomnia 63 lactic acidosis 63 MIRAPEX 63 Parkinson disease PD 63 nonhematologic adverse reactions 63 neurologic disorders 63 antioxidant supplementation 63 tardive dyskinesia 63 systolic hypertension 63 conventional DMARDs 63 symptomology 63 antiepileptics 63 cholinesterase inhibitor 63 EEG abnormalities 63 primidone 63 leukotriene receptor antagonists 63 adrenal suppression 63 pharmacokinetic interactions 63 agranulocytosis 63 ruboxistaurin 63 Tasimelteon 63 predisposing factor 63 Fingolimod 63 nonadherence 63 rufinamide 63 aripiprazole Abilify 63 lichen planus 63 allergic dermatitis 63 tricyclic anti depressants 63 underdiagnosis 63 thyroid dysfunction 63 ATACAND 63 Sleep disordered breathing 63 poor metabolizers 63 renal impairment 63 hallucinations delirium 63 INVEGA ® SUSTENNA ® 63 rasagiline mesylate 63 sJIA 63 bullous 63 probiotic supplementation 63 familial clustering 63 anticholinergics 63 ziconotide 63 elevated ALT 63 topical NSAIDs 63 emotional lability 63 topical calcineurin inhibitors 63 non aspirin NSAIDs 63 psychosocial functioning 63 divalproex sodium 63 HER2 overexpression 62 pramipexole 62 Natalizumab 62 neutropenic patients 62 extrapyramidal symptoms EPS 62 comorbid anxiety 62 Teriflunomide 62 acamprosate calcium 62 Angioedema 62 syncope fainting 62 lipid parameters 62 thyrotropin levels 62 antiarrhythmic drug 62 antidepressant efficacy 62 laboratory abnormalities 62 Sycrest 62 symptomatic VTE 62 AChE inhibitors 62 comorbid conditions 62 atopic eczema 62 CLA supplementation 62 neurosensory 62 dermopathy 62 renal insufficiency 62 biochemical abnormalities 62 acromegalic patients 62 endometrial hyperplasia 62 hyperkalemia 62 anticonvulsant drugs 62 Relapsing remitting MS 62 Starlix 62 gastro oesophageal reflux 62 hyperhomocysteinemia 62 virological response 62 Pramipexole 62 pharmacological interventions 62 COPD exacerbations 62 RLS symptoms 62 vasogenic edema 62 neuroleptic drugs 62 nabilone 62 CYP #A# 62 lacosamide 62 pioglitazone HCl 62 Akathisia 62 androgen excess 62 Effexor venlafaxine 62 Parkinsonian symptoms 62 IGFD 62 osteosarcomas 62 ocular adverse 62 asthma exacerbations 62 cardiac conduction 62 tricyclic antidepressants 62 receiving VELCADE 62 recurrent glioblastoma multiforme 62 Lantus insulin 62 tricyclics 62 inflammatory biomarkers 62 Nocturia 62 Tolvaptan 62 generalized tonic clonic seizures 62 SUSTENNA TM 62 affective psychosis 62 atypical femur fractures 62 unknown etiology 62 hemorrhagic complications 62 ADAGIO study 62 rheumatoid arthritis osteoarthritis ankylosing 62 glatiramer acetate 62 Tardive Dyskinesia 62 metabolic parameters 62 neurologic dysfunction 62 chronic thromboembolic pulmonary 62 MERLIN TIMI 62 ADPKD 62 affective disorder 62 COREG 62 inhaled bronchodilators 62 inhaled glucocorticoids 62 teriflunomide 62 Adverse effects 62 nausea constipation 62 Depressive symptoms 62 COPAXONE R 62 Focalin XR 62 fibromyalgia syndrome 62 AA Amyloidosis 62 pharmacokinetic interaction 62 progressive neurodegenerative disorder 62 paricalcitol 62 psychiatric morbidity 62 Neupro R 62 hepatic failure 62 postmarketing adverse 62 lipid lowering medications 62 Bipolar Mania 62 SGS# 62 varicella infection 62 atrophic gastritis 62 urticaria hives 62 unmeasured factors 62 PDE 5i 62 Serious adverse reactions 62 Alzheimer Disease AD 62 paroxetine sertraline 62 Suicidal thoughts 62 ziprasidone 62 REMINYL ® 62 corticosteroid therapy 62 reboxetine 62 Acute Bacterial Sinusitis ABS 62 antiepileptic drugs AEDs 62 OAB symptoms 62 GnRH agonists 62 MULTAQ 62 autoimmune thyroid 62 Bronchiectasis 62 Lu AA# 62 AZILECT 62 immune thrombocytopenic purpura 62 generalized epilepsy 62 Prostatitis 62 cardiac toxicity 62 thromboembolic disease 62 cardiac repolarization 62 quetiapine 62 ACTOplus met XR 62 dysthymia 62 Risperidone 62 antidepressants SSRIs 62 Acute pancreatitis 62 NATRECOR ® 62 neuroleptic malignant syndrome 62 prucalopride 62 habitual snoring 61 statins cholesterol lowering 61 valvular heart 61 aminotransferases 61 HRQOL 61 desvenlafaxine succinate 61 non selective NSAIDs 61 macrovascular events 61 pharmacologic treatments 61 plasma pharmacokinetics 61 neurologic complications 61 PsA 61 paliperidone 61 mirtazapine 61 nonalcoholic steatohepatitis NASH 61 antiplatelet drugs 61 primary Restless Legs 61 osteoarthritis rheumatoid arthritis 61 neurocognitive disorder 61 CYP#C# genotype 61 RRMS patients 61 post herpetic neuralgia PHN 61 lipid lowering medication 61 elevated triglyceride levels 61 hyperalgesia 61 sleep apneas 61 Antidepressant medications 61 interstitial pneumonia 61 RAS blockers 61 MEVACOR 61 montelukast 61 Hydroxyurea 61 proliferative retinopathy 61 comorbid psychiatric disorders 61 fluvastatin 61 rheumatic disorders 61 dopamine antagonists 61 Vitamin B# deficiency 61 alfuzosin 61 serum BDNF 61 gastrointestinal toxicity 61 Rheumatoid Arthritis RA 61 candidemia 61 tonic clonic seizures 61 KAPIDEX 61 schizophreniform disorder 61 hypercalcaemia 61 hyperactivity inattention 61 poststroke 61 Venous thromboembolism 61 gabapentin Neurontin 61 INVEGA 61 NATRECOR R 61 danazol 61 prostate carcinogenesis 61 mycophenolate mofetil 61 Serious Adverse Events 61 antihypertensive therapy 61 elevated serum creatinine 61 macroalbuminuria 61 prenatal exposures 61 atherogenic dyslipidemia 61 symptomatic hyponatremia 61 psychotic symptoms 61 carotid IMT 61 potassium sparing diuretics 61 hepatic toxicity 61 parasomnias 61 lupus scleroderma 61 behavioral abnormalities 61 androgen depletion 61 thromboembolic events 61 syncopal episode 61 atherothrombotic disease 61 nephrotoxicity 61 oral antidiabetic drugs 61 neurologic sequelae 61 HBeAg negative 61 Anticonvulsants 61 gastrointestinal disturbances 61 citalopram 61 prodromal symptoms 61 Parnate 61 psychosocial variables 61 liver dysfunction 61 analgesic medications 61 abdominal adiposity 61 Neuroleptic Malignant Syndrome NMS 61 urinary incontinence UI 61 INFERGEN 61 postoperative AF 61 somatostatin analog 61 valvular heart disease 61 KCNH2 61 escitalopram Lexapro 61 somatic complaints 61 Chronic ITP 61 methylphenidate Ritalin 61 severe exacerbations 61 DMARDS 61 TNF antagonist 61 XMRV infection 61 Celebrex celecoxib 61 nasopharyngitis headache 61 canakinumab 61 artery stenosis 61 androgen deprivation 61 dysmenorrhoea 61 subclinical atherosclerosis 61 nasal polyposis 61 G6PD deficiency 61 Serotonin syndrome 61 typical antipsychotics 61 recurrent abdominal pain 61 ritonavir boosted 61 carotid stenosis 61 diabetic gastroparesis 61 TMP SMX 61 Hematologic 61 hypocalcaemia 61 hypertension diabetes mellitus 61 delayed gastric emptying 61 SIBO 61 gastro esophageal reflux 61 hepatic dysfunction 61 tryptophan depletion 61 loop diuretic 61 SSRI SNRI 61 premorbid 61 hepatic encephalopathy HE 61 reuptake inhibitor 61 olanzapine Zyprexa 61 QTc interval 61 urinary symptoms 61 antiarrhythmic 61 trastuzumab Herceptin ® 61 liver toxicity 61 diarrhea predominant IBS 61 electrolyte disturbances 61 Overactive bladder 61 Alequel 61 Vimpat R 61 somatostatin analogs 61 telithromycin 61 levetiracetam 61 Hp2 2 61 Generalised Anxiety Disorder 61 hypovolemia 61 nociceptive pain 61 ARCOXIA 61 unipolar depression 61 Mirtazapine 61 shorter telomere length 61 AZILECT ® 61 loop diuretics 61 INCB# [003] 61 SGPT 61 Prozac fluoxetine 61 dysmotility 61 eculizumab therapy 61 acamprosate 61 eosinophilic pneumonia 61 syndromic 61 GBA mutations 61 receiving XGEVA 61 intra abdominal abscess 61 antidiabetic medications 61 methimazole 61 tranylcypromine 61 electrolyte abnormalities 61 hepatic enzymes 61 angioedema 61 testicular tumors 61 beta blocker therapy 61 hyperacute 61 rheumatic disease 61 lupus erythematosus 61 acitretin 61 Telithromycin 61 concomitant AEDs 61 biologic DMARD 61 colorectal adenomas 61 AAT deficiency 61 ischemic colitis 61 radiographic findings 61 metastatic neuroendocrine tumors 61 antiepileptic drug 61 quetiapine fumarate 61 clinically meaningful improvements 61 ADHD symptoms 61 beta carotene supplementation 61 pharmacodynamic parameters 61 pulmonary exacerbations 61 galantamine 61 Mild Cognitive Impairment 61 hyperreflexia 61 JANUMET 61 HPA axis 61 cranial irradiation 61 bacterial prostatitis 61 prazosin 61 amnestic MCI 61 Observational studies 61 ECG abnormalities 61 PNH patients 61 chlamydial infections 61 intracranial hemorrhage ICH 61 Postoperative complications 61 Glucocorticoids 61 nonalcoholic steatohepatitis 61 bladder dysfunction 61 anticoagulant warfarin 61 rosuvastatin Crestor 61 refractory gout 61 ß blockers 61 gonococcal 61 somnolence sleepiness 61 PEGINTRON TM 61 prostate cancer CaP 61 nitrofurantoin 61 excessive sleepiness 61 TMS Therapy 61 ORENCIA ® 61 lumiracoxib 61 ICD shocks 61 upper gastrointestinal bleeding 61 Quetiapine 61 salmeterol Serevent 61 hyperparathyroidism 61 arterial hypertension 61 prolactin elevation 60 paroxetine Seroxat 60 Tasigna prolongs 60 Olanzapine 60 BoNTA 60 Magnesium deficiency 60 Cholinesterase inhibitors 60 rheumatological 60 intractable hiccups 60 Daytime sleepiness 60 thromboembolism 60 neuro psychiatric disorders 60 Potiga 60 acarbose 60 infliximab Remicade 60 alpha interferons 60 prolactin levels 60 Nonalcoholic Fatty Liver Disease 60 pheochromocytoma 60 Reminyl galantamine 60 Generalized anxiety disorder 60 MAO inhibitors 60 DPNP 60 brivaracetam 60 acute myocardial infarction MI 60 sedating medications 60 CONCERTA 60 Rasagiline 60 tibolone 60 aspirin clopidogrel 60 gastrointestinal adverse reactions 60 Certolizumab pegol 60 CIMZIA TM certolizumab pegol 60 guanfacine 60 decompensated heart failure 60 receptor inhibitor 60 neurodevelopmental outcome 60 ramelteon 60 desvenlafaxine 60 autoinflammatory diseases 60 schizophrenia schizoaffective disorder 60 hypersensitivity allergic reactions 60 Serdolect ® 60 recurrent seizures 60 leucopenia 60 intracranial stenosis 60 renoprotective 60 Major depressive disorder 60 anxiolytic 60 lenalidomide dexamethasone 60 leukoencephalopathy 60 somnolence dizziness 60 haematological toxicity 60 C1 INH deficiency 60 pathophysiologic 60 K ras mutations 60 Glimepiride 60 Febrile neutropenia 60 Arranon 60 optic neuropathy NAION 60 ULORIC 60 tigecycline 60 neurologic abnormalities 60 decompensation 60 daytime somnolence 60 heparin induced thrombocytopenia 60 levodopa carbidopa 60 serious neuropsychiatric symptoms 60 newer antipsychotics 60 neuropsychiatric diseases 60 intracerebral haemorrhage 60 CIMZIA ™ 60 pericardial effusion 60 rheumatoid arthritis psoriatic arthritis 60 EBV infection 60 abacavir Ziagen 60 beta interferons 60 salmeterol fluticasone 60 thrombocytopenia neutropenia 60 selective modulator 60 Candesartan 60 salivary cortisol 60 coadministration 60 orthostatic hypotension 60 sustained ventricular tachycardia 60 AZILECT R 60 Heavy menstrual bleeding 60 treatment emergent AEs 60 Safinamide 60 rasagiline 60 BPS IC 60 Pathological gambling 60 interpersonal psychotherapy 60 NIASPAN 60 QTc intervals 60 Atomoxetine 60 pharmacological approaches 60 nonpsychotic 60 symptom severity 60 interferon therapy 60 acute psychosis 60 HAV infection 60 Epidemiologic studies 60 non cirrhotic portal 60 metabolic acidosis 60 dysthymic disorder 60 gallstone disease 60 premenstrual dysphoric disorder 60 sub syndromal 60 enalapril 60 invasive fungal infections 60 protease inhibitor PI 60 nausea vomiting headache 60 hepatotoxic 60 atrial tachyarrhythmias 60 Korsakoff syndrome 60 duloxetine Cymbalta 60 Pfizer Aricept 60 hippocampal volume 60 demyelinating 60 cryptogenic 60 atypical antipsychotics 60 silent myocardial ischemia 60 neutropenia dehydration dyspnea 60 glucocorticoid therapy 60 PRISTIQ 60 cilostazol 60 Uncontrolled hypertension 60 cystic fibrosis chronic pancreatitis 60 INVEGA ™ 60 fatal anaphylactic 60 posaconazole 60 squamous cell lung cancer 60 treatment emergent hyperglycemia 60 statin medications 60 affective psychoses 60 hypomanic episodes 60 phenytoin 60 induced ischemia 60 intravascular hemolysis 60 ibandronate 60 Dose adjustments 60 Vitamin D insufficiency 60 newer antipsychotic medications 60 INVEGA ® SUSTENNA TM 60 coronary insufficiency 60 immunological responses 60 relapsed MM 60 LUTS 60 Hashimoto thyroiditis 60 prodrome 60 neurocognitive function 60 levodopa induced 60 cerebral vasospasm 60 systemic corticosteroid 60 epilepsies 60 somnolence sedation 60 hepatic insufficiency 60 daytime alertness 60 Autoimmune disorders 60 Bosentan 60 depression suicidal ideation 60 Wernicke Korsakoff syndrome 60 Enbrel Humira 60 antidepressive 60 acute phosphate nephropathy 60 eosinophilia 60 MMSE scores 60 LYSTEDA 60 rotigotine transdermal patch 60 variceal bleeding 60 cholinergic tone 60 brain lesions 60 symptomatic intracranial 60 tocilizumab 60 pharmacologic therapies 60 imatinib resistance 60 subclinical hyperthyroidism 60 ALT elevations 60 Geodon ziprasidone 60 ABCB1 60 antiplatelet therapies 60 β blocker 60 inhaled corticosteroid therapy 60 Non inferiority 60 chills fever headache 60 paliperidone ER 60 polymyalgia rheumatica 60 sulfasalazine 60 antidepressants fluoxetine 60 chronic myocardial ischemia 60 alemtuzumab treated 60 constipation nausea 60 hypoparathyroidism 60 atypicals 60 active ankylosing spondylitis 60 lipid lowering therapies 60 symptomatic paroxysmal AF 60 Eli Lilly Cymbalta 60 Valdoxan 60 VAPRISOL 60 APOE genotype 60 genotypic resistance 60 PEGylated interferon beta 1a 60 hemorrhagic cystitis 60 immunosuppressive agents 60 anti epileptics 60 glycated hemoglobin levels 60 MIRAPEX ER 60 Vimpat lacosamide 60 elevated creatinine 60 phytoestrogen intake 60 SGAs 60 Azilect ® 60 migraineurs 60 serotonin norepinephrine reuptake inhibitor 60 hypoglycemic events 60 antiemetics 60 oral antidiabetic medication 60 NMDA antagonists 60 olanzapine quetiapine 60 hyperlipidaemia 60 underlying pathophysiology 60 cerebral atrophy 60 nortriptyline Pamelor 60 anticonvulsant medication 60 Trandolapril 60 lamotrigine 60 headache nasopharyngitis 60 guanfacine extended release 60 HPA axis suppression 60 Syndrome RLS 60 REMICADE ® 60 VADT 60 comorbid ADHD 60 atherosclerotic vascular disease 60 bardoxolone methyl 60 psychomotor retardation 60 constipation OIC 60 dopamine agonists 60 incidence ≥ 60 androgen suppression 60 Arrhythmias 60 ACTEMRA TM 60 microbleeds 60 acute mania 60 hepatorenal syndrome 60 AST ALT 60 SEROQUEL XR 60 thromboembolic complications 60 AVANDIA 60 untreated celiac disease 60 Anxiety disorders 60 gemifloxacin 60 heterozygous FH 60 BARACLUDE ® 60 subconjunctival hemorrhage 60 fingolimod 60 concomitant medications 60 Allergic Rhinitis 60 SEROQUEL R 60 nonmelanoma skin cancers 60 Irritable bowel syndrome 60 premenstrual symptoms 60 isolated systolic hypertension 60 neuropathologic 60 nonpharmacologic 60 ACIPHEX 60 psychostimulants 60 anticholinergic 60 pathologic fractures 60 clinically meaningful reductions 60 chronic eosinophilic leukemia 60 ragweed allergic 60 Sjögren syndrome 60 overt nephropathy 60 Avandia Actos 60 Social Phobia 60 antiandrogens 60 severe hypoglycaemia 60 ACEIs 60 Chronic Fatigue Syndrome CFS 60 systemic juvenile idiopathic 60 sildenafil Viagra 60 placebo controlled clinical 60 antidiabetic drugs 60 pregabalin Lyrica 60 CSF biomarkers 60 lupus nephritis 60 glitazone 60 NNT = 60 irritable bowel syndrome IBS 60 Alzheimer disease vascular dementia 60 intracranial hypertension 59 serotonin syndrome 59 onset seizures 59 suicidality 59 white matter hyperintensities 59 nocturnal enuresis 59 arterial thromboembolic events 59 paliperidone palmitate 59 PAOD 59 therapeutic regimens 59 LHRH agonists 59 systemic lupus erythematosus SLE 59 atopic disorders 59 benazepril 59 euthymic 59 SJIA 59 atopic sensitization 59 extrapyramidal 59 bronchopulmonary dysplasia 59 subclinical disease 59 DULERA 59 ACTOplus met 59 metformin sulfonylurea 59 Skin rashes 59 chronic renal insufficiency 59 chronicity 59 myalgias 59 bipolar illness 59 hyperinsulinemia 59 latrepirdine 59 levetiracetam Keppra 59 serum lipids 59 Aortic stenosis 59 antidiabetic drug 59 primary hypercholesterolemia 59 esomeprazole Nexium 59 Helicobacter pylori eradication 59 histologic subtype 59 erythropoietic 59 eszopiclone 59 topical corticosteroids 59 aripiprazole 59 allergen immunotherapy